AGM Notes, page-91

Stayer

I was not at the AGM

However the announcemengs pending

IE

First dosing of Dep Carbazitaxel patients (already enrolling them - speculation on my part based on previous comments of graphic posted showing initiation of trial)

Preclinical data on AZD0046 by Astrazeneca (the superlatives by CEO of Starpharma and Susan from AstraZeneca really show how exciting this particular formulation is)

And unless I am wrong - anytime in January these will be forthcoming with a immense share price appreciation

Remember when script was hovering around 75 cents and members from this forum indicated not to dilly dally and if not invested in Starpharma - now was the time

Well

I am telling you the same now - once the above announcements are made public - we should see a once again see doubling of price

So - if you do not want to miss the boat - now...... and I mean now is a fantastic time to dip your toes in a fantastically inexpensive Starpharma

Of course my opinion only